Michael Branagan-Harris

Founder & CEO, Device Access, UK

Since 1989, Michael Branagan-Harris, CEO of Device Access UK Ltd has been involved in accelerating patient access to great technology in the UK’s health care system – the National Health Service or NHS.

During his role in sales, he introduced the Lap Band for obesity, endovascular grafts, novel endo laparoscopic surgery devices and the DaVinci robot.

From 2006-2009 Michael ran VNUS Medical UK Ltd, a subsidiary of VNUS Inc San Jose California. Where he introduced VNUS Closure®, a novel minimally invasive treatment alternative to painful vein stripping surgery. Following his team’s efforts, VNUS Closure was showcased by The NHS Innovation Centre, leading to accelerated adoption and diffusion across the NHS and VNUS Medical was subsequently purchased by Covidien for over $500M US

Today VNUS Closure has fully replaced traditional vein stripping surgery as the procedure of choice, saving the NHS over 50,000 valuable bed days a year.

Michael incorporated Device Access UK in 2010 and the business is based on the University of Southampton Science Park. Since then his team has helped hundreds of Medical Device and Diagnostic companies navigate their way into the NHS and has helped over 50 companies navigate various NICE evaluation programmes for approval and recommendations

Device Access was granted a commercial licence from NHS Digital to access over 1.2 Billion NHS England patient electronic health records. This data allows them to examine diagnosis, procedure and spend data, nationally and by each NHS Hospital in England, and in turn enables Device Access to see how their client’s technology could affect the current patient pathway, assist in building a value story with NHS Stakeholders and a solid business case for local and national NHS Hospital adoption.

Today Michaels team consists of specialists from NHS Hospital engagement and Change Management, Health Economics and Outcomes research, fast- track publications of economic evidence, and a new online service called Hepisodes™ that demonstrates the problem solved by the adoption of new technologies on a hospital and National level to expedite and justify adoption

www.deviceaccess.co.uk